Gamma Diagnostics, Inc. (Formerly Gamma Therapeutics)

GDx is an early stage biotech start up developing companion diagnostics for COVID-19, other infectious and inflammatory diseases.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Portland, OR, USA
  • Currency USD
  • Founded October 2009
  • Employees 4
  • Incorporation Type C-corp
  • Website gammadiagnostics.com

Company Summary

We specialize in developing novel diagnostics that are better quantitative indicators of the inflammatory response in infectious and chronic diseases (such as SARS-CoV-2, Dengue fever, rheumatoid arthritis, inflammatory bowel disease, and others) to determine the right course of treatment, improve efficacy of care and thereby save more patient lives.

Team

  • David Henry Farrell, PhD
    Founder & Chief Scientific Officer

    37-year researcher in thrombosis, hemostasis and coagulation research; 19 years as a Principal Investigator; Professor of Surgery, Department of Surgery, OHSU; Director, Health Sciences Entrepreneurship Certificate Program; Fellow of the American Heart Association; BS in Biochemistry, UCLA; PhD in Biological Sciences, Univ. of California, Irvine, Senior Fellow in Biochemistry, Univ. of Washington.

Advisors

  • Candace Clement
    Accountant
    Unconfirmed
    Michael Phillips, David Wright Tremaine Lawyer
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free